Shilpa Medicare gets USFDA nod for cancer treatment injection

Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.

Original source: https://health.economictimes.indiatimes.com/news/pharma/shilpa-medicare-gets-usfda-nod-for-cancer-treatment-injection/67336387?utm_source=RSS&utm_medium=ETRSS

Related Posts